Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization
Muhammad
Sarfraz
*ab,
Gautam
Behl
a,
Sweta
Rani
a,
Niall
O'Reilly
a,
Peter
McLoughlin
a,
Orla
O'Donovan
a,
Alison L.
Reynolds
cd,
John
Lynch
a and
Laurence
Fitzhenry
*a
aOcular Therapeutics Research Group (OTRG), Pharmaceutical & Molecular Biotechnology Research Centre (PMBRC), South East Technological University, Waterford X91 KOEK, Waterford, Ireland. E-mail: muhammad.sarfraz@setu.ie
bFaculty of Pharmacy, The University of Lahore, Lahore 56400, Pakistan
cUCD School of Veterinary Medicine, Dublin, Ireland
dUCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD), Dublin D04 V1W8, Ireland
First published on 2nd May 2025
Abstract
Correction for ‘Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization’ by Muhammad Sarfraz et al., Nanoscale Adv., 2025, https://doi.org/10.1039/d4na01086h.
The authors regret that the incorrect spelling of the name of author Gautam Behl was used in this manuscript. The corrected spelling for this author name is as above. All affiliations for this author remain the same.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2025 |